Cytovation
PrivateLast Round
Series A
Extension
Apr 23, 2025
Total Funding Raised
$34M
Company Overview
Cytovation ASA is a clinical-stage biotech company that develops treatments for solid tumors in oncology and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytovation Comparables
Compare Cytovation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lytix Biopharma AS | 84% | |
| Sapience Therapeutics | 78% | |
| Intensity Therapeutics, Inc. | 77% |
Cytovation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 23, 2025 | ||||
| Series A Extension | Jun 2, 2023 | ||||
| Series A | Jan 25, 2022 | ||||
| Private Placement | Jan 8, 2018 | ||||
| Private Placement | Jun 29, 2017 |
Key People
Founding team and executive leadership
Cytovation Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 669% MoM, reaching 3.2K.
- Apr 23, 2025
$6M round led by Sandwater.
Cytovation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cytovation's valuation, stock price, and market status.
Is Cytovation a public or private company?
Cytovation is a private company.
What is the current stock price of Cytovation?
Cytovation is a private company with no public stock price. No recent secondary market data is available.
How much is Cytovation worth (valuation)?
Valuation information for Cytovation is not publicly available.
Can I buy Cytovation stock?
Cytovation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cytovation's last funding round?
Cytovation's most recent funding round was Series A Extension on April 23, 2025.
Who are the main investors in Cytovation?
Key investors in Cytovation include Canica, Sandwater.
Will Cytovation IPO soon?
No public IPO plans have been announced for Cytovation.
How can I track Cytovation secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cytovation's secondary market activity and sign up for updates.